Molecular targeting in acute myeloid leukemia

about

A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine

P2860

Q49556327-4849F83E-C7F0-4B67-88AC-A9610D05ECBA Q57022275-2AE811B5-8C1C-4173-9396-DDF6EE4E1B17

P2860

Molecular targeting in acute myeloid leukemia

Item

http://www.wikidata.org/entity/Q41558732

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Molecular targeting in acute myeloid leukemia

@en

type

Item

label

Molecular targeting in acute myeloid leukemia

@en

prefLabel

Molecular targeting in acute myeloid leukemia

@en

P1476

Molecular targeting in acute myeloid leukemia

@en

P2093

Patrycja M Dubielecka

http://www.w3.org/2001/XMLSchema#string

Vikram M Raghunathan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

DNMT3A Mutations in Acute Myeloid Leukemia

Structural Basis for Acetylated Histone H4 Recognition by the Human BRD2 Bromodomain

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.

hDOT1L links histone methylation to leukemogenesis.

Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells

Compassionate use of sorafenib in FLT3-ITD-positive acute myeloid leukemia: sustained regression before and after allogeneic stem cell transplantation

DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy

P2888

s12967-017-1281-x

P304

183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-017-1281-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Lim

P5008

ScienceSource

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091371068

http://www.w3.org/2001/XMLSchema#string

P698

28851395

http://www.w3.org/2001/XMLSchema#string

P921

acute myeloid leukemia

P932

5576374

http://www.w3.org/2001/XMLSchema#string

Molecular targeting in acute myeloid leukemia

about

P2860

P2860

Molecular targeting in acute myeloid leukemia

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932